Annex Advisory Services’s Novavax NVAX Stock Holding History

Annex Advisory Services’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-1,635	Closed	-$231K	–	116
2015 Q3	$231K	Buy	1,635 +5	+0.3%	+$1.12K	0.08%	100
2015 Q2	$363K	Buy	1,630 +1,000	+159%	+$176K	0.12%	82
2015 Q1	$104K	Buy	+630	New	+$102K	0.03%	115

Other funds holding NVAX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Annex Advisory Services's NVAX Position: Q4 2015 in Review

Annex Advisory Services sold out of Novavax (NVAX) in Q4 2015, closing a stake of 1,635 shares — an estimated $231K sold.

Annex Advisory Services first reported a position in NVAX in Q1 2015 and held it in 3 quarters. The position peaked at $363K in Q2 2015. 173 funds tracked by Wall St. Rank hold NVAX as of Q4 2015.

Annex Advisory Services reported no remaining Novavax position as of Q4 2015 after selling out during the quarter.
Annex Advisory Services sold 1,635 Novavax shares in Q4 2015, an estimated $231K.
Annex Advisory Services first reported a position in Novavax in Q1 2015 and held it in 3 quarters.
Annex Advisory Services's Novavax position peaked at $363K in Q2 2015.
173 funds tracked by Wall St. Rank held Novavax as of Q4 2015.

Based on Annex Advisory Services's 13F filing for Q4 2015, filed 1 Feb 2016.